YDES — structural market context
Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.
What changed
As of the close on Nov 2. Each line shows the earlier value, the later value and their dates.
Change from the Oct 30 close to the Nov 2 close: +0.51%.
1.27× its 20-session average on Nov 2.
Includes pre- and post-market trading.
Short interest 192K shares (settlement Oct 15) vs 177K (Sep 30).
No new file loaded in this window. Latest file: settlement Oct 15, loaded Oct 27.
Latest file (settlements Sep 15–Sep 30, published Oct 16): 9 days with fails, largest 122K shares on Sep 28.
Previous file (settlements Sep 1–Sep 14, published Sep 30): 3 days with fails, largest 3K shares on Sep 9.
No new file loaded in this window.
None recorded in this window.
YDES events and their magnitude
YDES short interest & days to cover
FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-10-15 (19d ago)
YDES fails-to-deliver (FTD)
SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.
YDES insider buying and selling (Form 4)
Last 12 months, Form 4 codes P and S: 3 purchases · 0 sales
SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.
Frequently asked questions
Other companies in the same SEC industry: Services-Medical Laboratories
Industry: SIC code 8071 as recorded on SEC EDGAR.
YDES: the full history
Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.
Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.